We are live on ! Find out more
RVMDW icon

Revolution Medicines Inc Warrant

22 hedge funds and large institutions have $104M invested in Revolution Medicines Inc Warrant in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

476% more capital invested

Capital invested by funds: $18.1M → $104M (+$86.2M)

0.26% more ownership

Funds ownership: 91.16%91.43% (+0.26%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

4% less funds holding

Funds holding: 2322 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
3
Reduced
3
Closed
4
Calls
$814K
Puts
Net Calls
+$814K
Net Calls Change
+$659K

RVMDW Hedge Fund Activity: Q2 2026 in Review

22 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q2 2026, worth a combined $104M — up 476% from $18.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RVMDW and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.

The largest buyer was LMR Partners, adding an estimated $6.65M. The largest seller was Sculptor Capital, cutting an estimated $1.35M.

  • 22 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q2 2026, down from 23 in Q1 2026.
  • Funds reported $104M of Revolution Medicines Inc Warrant stock for Q2 2026, up 476% quarter-over-quarter.
  • 3 funds opened new Revolution Medicines Inc Warrant positions in Q2 2026 and 4 closed out, a net change of -1 holder.
  • The largest Revolution Medicines Inc Warrant buyer in Q2 2026 was LMR Partners, an estimated $6.65M added.
  • The largest Revolution Medicines Inc Warrant seller in Q2 2026 was Sculptor Capital, an estimated $1.35M sold.

Based on aggregated 13F filings for Q2 2026.